Three-year surveillance of community-acquired Staphylococcus aureus infections in children

Background. Methicillin-resistant Staphylococcus aureus ( MRSA) isolates are increasingly frequent causes of skin and soft-tissue infections or invasive infections in many communities. Methods. Prospective surveillance for community-acquired S. aureus infections at Texas Children's Hospital was initiated on 1 August 2001. Infections meeting the definition of community-acquired were identified. Demographic and clinical data were collected. Antibiotic susceptibilities, including inducible resistance to macrolide, lincosamide, and streptogramin B ( MLSB), were determined in the clinical microbiology laboratory with the methodology of the NCCLS. All data were entered into a computer database. Data were analyzed by x 2 tests. Results. From 1 August 2001 to 31 July 2004, the percentage of community-acquired S. aureus isolates that were methicillin resistant increased from 71.5% ( 551 of 771 isolates) in year 1 to 76.4% ( 1193 of 1562 isolates) in year 3 (P = .008). The number of both community-acquired MRSA (CA-MSRA) isolates and community-. 008 acquired methicillin-susceptible S. aureus (CA-MSSA) isolates increased yearly, but the rate of increase was greater for the CA-MRSA isolates. Among the CA-MRSA isolates, 2542 (95.6%) were obtained from children with skin and soft-tissue infections, and 117 (4.4%) were obtained from children with invasive infections. Overall, 62% of children with CA-MRSA isolates and 53% of children with CA-MSSA isolates were admitted to the hospital (P = .0001). The rate of clindamycin resistance increased significantly for both CA-MRSA isolates (P = .003) and CA-MSSA isolates (P = .003) over the 3 years. MLSB inducible resistance was found in 27 (44%) of 62 clindamycin- resistant CA-MSSA isolates, compared with 6 (4.5%) of 132 clindamycin- resistant CA-MRSA isolates (P < .0001). Conclusions. CA-MRSA isolates account for an increasing percentage and number of infections at Texas Children's Hospital. Clindamycin resistance increased among community- acquired S. aureus isolates. Community surveillance of community- acquired S. aureus infections is critical to determine the appropriate empiric antibiotic treatment for either local or invasive infections.